Shenson, JA, Zafereo, M, Lee, M, Contrera, KJ, Feng, L, Boonsripitayanon, M, Gross, N, Goepfert, RP, Maniakas, A, Wang, JR, Grubbs, L, Vaporciyan, AA, Hofstetter, WL, Swisher, SG , Mehran, RJ, Rice, DC, Sepesi, B, Antonoff, MB, Cabanillas, ME, Busaidy, NL, Dadu, R, Silver, NL
This phase may include peptides that support Sleep quality and recovery Muscle repair Joint healing Cellular energy production Phase 3 Long-term performance and resilience Protocols may eventually focus on supporting Exercise performance Work and lifestyle demands Travel and stress recovery Age-related metabolic changes Adjustments are guided by lab results, clinical evaluation, and patient feedback
doi: 10.1530/JME-17-0196
Navigating the neurobiology of Parkinsons: the impact and potential of -synuclein